Novartis AG
Aminoheteroaryl benzamides as kinase inhibitors
Last updated:
Abstract:
The present invention provides a compound of Formula (I) or a salt thereof; ##STR00001## and therapeutic uses of these compounds. The present invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds with a therapeutic co-agent.
Status:
Grant
Type:
Utility
Filling date:
5 Dec 2018
Issue date:
26 May 2020